The placebo trial
Less than one letter, with the glasses that help you most.
One hundred adults over 50, with mild to moderate macular degeneration and vision better than 20/70 in at least one eye, took 20 milligrams a day. Three months on saffron, three months on a placebo, then they switched. Anyone already taking an AREDS supplement kept it. Best-corrected acuity improved by 0.69 letters. The retinal recording, the mfERG, answered 0.17 milliseconds sooner. In the people who stayed on AREDS, the chart moved 0.73 letters and the response density rose 2.8 percent. Side effects were not clearly different from placebo.
